|
1
|
Tomiyama N, Honda O, Tsubamoto M, Inoue A,
Sumikawa H, Kuriyama K, Kusumoto M, Johkoh T and Nakamura H:
Anterior mediastinal tumors: Diagnostic accuracy of CT and MRI. Eur
J Radiol. 69:280–288. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sakai S, Murayama S, Soeda H, Matsuo Y,
Ono M and Masuda K: Differential diagnosis between thymoma and
non-thymoma by dynamic MR imaging. Acta Radiol. 43:262–268. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Usuda K, Maeda S, Motono N, Ueno M, Tanaka
M, Machida Y, Matoba M, Watanabe N, Tonami H, Ueda Y and Sagawa M:
Diffusion weighted imaging can distinguish benign from malignant
mediastinal tumors and mass lesions: Comparison with positron
emission tomography. Asian Pac J Cancer Prev. 16:6469–6475. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yabuuchi H, Matsuo Y, Abe K, Baba S,
Sunami S, Kamitani T, Yonezawa M, Yamasaki Y, Kawanami S, Nagao M,
et al: Anterior mediastinal solid tumours in adults:
Characterisation using dynamic contrast-enhanced MRI,
diffusion-weighted MRI, and FDG-PET/CT. Clin Radiol. 70:1289–1298.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kubota K, Yamada S, Kondo T, Yamada K,
Fukuda H, Fujiwara T, Ito M and Ido T: PET imaging of primary
mediastinal tumours. Br J Cancer. 73:882–886. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kitami A, Sano F, Ohashi S, Suzuki K,
Uematsu S, Suzuki T and Kadokura M: The usefulness of
positron-emission tomography findings in the management of anterior
mediastinal tumors. Ann Thorac Cardiovasc Surg. 23:26–30. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Morita T, Tatsumi M, Ishibashi M, Isohashi
K, Kato H, Honda O, Shimosegawa E, Tomiyama N and Hatazawa J:
Assessment of mediastinal tumors using SUVmax and
volumetric parameters on FDG-PET/CT. Asia Ocean J Nucl Med Biol.
5:22–29. 2017.PubMed/NCBI
|
|
8
|
Sung YM, Lee KS, Kim BT, Choi JY, Shim YM
and Yi CA: 18F-FDG PET/CT of thymic epithelial tumors: Usefulness
for distinguishing and staging tumor subgroups. J Nucl Med.
47:1628–1634. 2006.PubMed/NCBI
|
|
9
|
Luzzi L, Campione A, Gorla A, Vassallo G,
Bianchi A, Biggi A and Terzi A: Role of fluorine-flurodeoxyglucose
positron emission tomography/computed tomography in preoperative
assessment of anterior mediastinal masses. Eur J Cardiothorac Surg.
36:475–479. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Igai H, Matsuura N, Tarumi S, Chang SS,
Misaki N, Go T, Ishikawa S and Yokomise H: Usefulness of
[18F]fluoro-2-deoxy-D-glucose positron emission tomography for
predicting the world health organization malignancy grade of thymic
epithelial tumors. Eur J Cardiothorac Surg. 40:143–145. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lococo F, Cesario A, Okami J, Cardillo G,
Cavuto S, Tokunaga T, Apolone G, Margaritora S and Granone P: Role
of combined 18F-FDG-PET/CT for predicting the WHO malignancy grade
of thymic epithelial tumors: A multicenter analysis. Lung Cancer.
82:245–251. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Purandare NC, Pramesh CS, Karimundackal G,
Jiwnani S, Agrawal A, Shah S, Agarwal JP, Prabhash K, Noronha V,
Joshi A, et al: Thymic epithelial tumors: Can fluorodeoxyglucose
positron emission tomography help in predicting histologic type and
stage? Indian J Cancer. 53:270–273. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Treglia G, Sadeghi R, Giovanella L,
Cafarotti S, Filosso P and Lococo F: Is (18)F-FDG PET useful in
predicting the WHO grade of malignancy in thymic epithelial tumors?
A meta-analysis. Lung Cancer. 86:5–13. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Toba H, Kondo K, Sadohara Y, Otsuka H,
Morimoto M, Kajiura K, Nakagawa Y, Yoshida M, Kawakami Y, Takizawa
H, et al: 18F-fluorodeoxyglucose positron emission
tomography/computed tomography and the relationship between
fluorodeoxyglucose uptake and the expression of hypoxia-inducible
factor-1α, glucose transporter-1 and vascular endothelial growth
factor in thymic epithelial tumours. Eur J Cardiothorac Surg.
44:e105–e112. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Seki N, Sakamoto S, Karube Y, Oyaizu T,
Ishihama H and Chida M: 18F-fluorodeoxyglucose positron
emission tomography for evaluation of thymic epithelial tumors:
Utility for world health organization classification and predicting
recurrence-free survival. Ann Nucl Med. 28:257–262. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fukumoto K, Taniguchi T, Ishikawa Y,
Kawaguchi K, Fukui T, Kato K, Matsuo K and Yokoi K: The utility of
[18F]-fluorodeoxyglucose positron emission tomography-computed
tomography in thymic epithelial tumours. Eur J Cardiothorac Surg.
42:e152–e156. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kaira K, Sunaga N, Ishizuka T, Shimizu K
and Yamamoto N: The role of [18F] fluorodeoxyglucose
positron emission tomography in thymic epithelial tumors. Cancer
Imaging. 11:195–201. 2011.PubMed/NCBI
|
|
18
|
Kumar A, Regmi SK, Dutta R, Kumar R, Gupta
SD, Das P, Halanaik D and Jindal T: Characterization of thymic
masses using (18)F-FDG PET-CT. Ann Nucl Med. 23:569–577. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim JY, Kim HO, Kim JS, Moon DH, Kim YH,
Kim DK, Park SI, Park YS and Ryu JS: (18)F-FDG PET/CT is useful for
pretreatment assessment of the histopathologic type of thymic
epithelial tumors. Nucl Med Mol Imaging. 44:177–184. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Benveniste MF, Moran CA, Mawlawi O, Fox
PS, Swisher SG, Munden RF and Marom EM: FDG PET-CT aids in the
preoperative assessment of patients with newly diagnosed thymic
epithelial malignancies. J Thorac Oncol. 8:502–510. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shinya T, Tanaka T, Soh J, Matsushita T,
Sato S, Toyooka S, Yoshino T, Miyoshi S and Kanazawa S: Diagnostic
value of dual-time-point F-18 FDG PET/CT and chest CT for the
prediction of thymic epithelial neoplasms. Acta Med Okayama.
71:105–112. 2017.PubMed/NCBI
|
|
22
|
Endo M, Nakagawa K, Ohde Y, Okumura T,
Kondo H, Igawa S, Nakamura Y, Tsuya A, Murakami H, Takahashi T, et
al: Utility of 18FDG-PET for differentiating the grade of
malignancy in thymic epithelial tumors. Lung Cancer. 61:350–355.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Terzi A, Bertolaccini L, Rizzardi G, Luzzi
L, Bianchi A, Campione A, Comino A and Biggi A: Usefulness of 18-F
FDG PET/CT in the pre-treatment evaluation of thymic epithelial
neoplasms. Lung Cancer. 74:239–243. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Park SY, Cho A, Bae MK, Lee CY, Kim DJ and
Chung KY: Value of 18F-FDG PET/CT for predicting the world health
organization malignant grade of thymic epithelial tumors: Focused
in volume-dependent parameters. Clin Nucl Med. 41:15–20. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Scagliori E, Evangelista L, Panunzio A,
Calabrese F, Nannini N, Polverosi R and Pomerri F: Conflicting or
complementary role of computed tomography (CT) and positron
emission tomography (PET)/CT in the assessment of thymic cancer and
thymoma: Our experience and literature review. Thorac Cancer.
6:433–442. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sandri A, Cusumano G, Lococo F, Alifano M,
Granone P, Margaritora S, Cesario A, Oliaro A, Filosso P, Regnard
JF and Ruffini E: Long-term results after treatment for recurrent
thymoma: A multicenter analysis. J Thorac Oncol. 9:1796–1804. 2014.
View Article : Google Scholar : PubMed/NCBI
|
